1990
DOI: 10.1016/0223-5234(90)90121-i
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological activity of iodinated and photosensitive derivatives of tetrabenazine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1993
1993
2011
2011

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…["C]TBZOH, and the presence of potential radiolabeled metabolites may complicate quantitative phannacokinetic modeling. As large substituents can be attached at the hydroxyl function of a-TBZOH and such derivatives retain high binding aSlnity for the monoamine vesicular transporter (Scherman er al., 1988;Aranda et al, 1990), we have investigated derivatives of TBZQH as possible improved, less metabolixed in viuo imaging agents. We report here the synthesis of the *Current address: PET Centre, Clarke Institute of Psychiatry, University of Toronto, Toronto, Ontario.…”
Section: Iilbodrctiodmentioning
confidence: 99%
See 1 more Smart Citation
“…["C]TBZOH, and the presence of potential radiolabeled metabolites may complicate quantitative phannacokinetic modeling. As large substituents can be attached at the hydroxyl function of a-TBZOH and such derivatives retain high binding aSlnity for the monoamine vesicular transporter (Scherman er al., 1988;Aranda et al, 1990), we have investigated derivatives of TBZQH as possible improved, less metabolixed in viuo imaging agents. We report here the synthesis of the *Current address: PET Centre, Clarke Institute of Psychiatry, University of Toronto, Toronto, Ontario.…”
Section: Iilbodrctiodmentioning
confidence: 99%
“…The synthesis of ["CjTBZOMe first required synthesis of a-TBZOH, which was prepared by modification of reported methods (Shwartz et al, 1966, Aranda et al, 1990, Scherman et al, 1981. Sodium borohydride reduction (3.5 equiv.)…”
Section: Discwsiollmentioning
confidence: 99%
“…Development of new imaging agents for the vesicular monoamine transporter will require a better knowledge of the structural requirements and limitations for high-affinity binding to the VMAT2. A number of benzisoquinolines have been prepared over the years, including (a) analogs of 2 with different 3-alkyl substituents, (b) derivatives of 1a with alkyl substituents at the 2-position, , and (c) benzisoquinoline analogs with amino, amido, and ester functional groups at the 2-position. , There has, however, never been a systematic study of the in vitro or in vivo structure−activity relationship of benzisoquinoline binding to the VMAT2 site (or, for that matter, any systematic study of the binding site requirement for VMAT2). Alterations of the structure of 2 do have profound effects on its biological activity; some modifications increase pharmacologic activity, while others produce differential depletions of certain monoamines .…”
Section: Introductionmentioning
confidence: 99%